Results 231 to 240 of about 208,651 (377)

68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning

open access: yesJournal of Nuclear Medicine, 2017
J. Calais   +18 more
semanticscholar   +1 more source

Deep vein thrombosis and prostatectomy [PDF]

open access: bronze, 1983
Keith N. Van Arsdalen   +4 more
openalex   +1 more source

Controversies in metastatic hormone‐sensitive prostate cancer

open access: yesCancer, Volume 131, Issue 16, 15 August 2025.
Abstract Metastatic hormone‐sensitive prostate cancer (mHSPC) is an incurable phase of prostate cancer. Diagnostic tools and management strategies for this complex disease are expanding. Despite these advances, more therapies may not be the optimal approach for all patients. This review explores four major controversies surrounding mHSPC management—the
Irene Tsung   +2 more
wiley   +1 more source

Artificial intelligence across the cancer care continuum

open access: yesCancer, Volume 131, Issue 16, 15 August 2025.
Abstract Artificial intelligence (AI) holds significant potential to enhance various aspects of oncology, spanning the cancer care continuum. This review provides an overview of current and emerging AI applications, from risk assessment and early detection to treatment and supportive care.
Irbaz Bin Riaz   +2 more
wiley   +1 more source

The carbon footprint of transperineal prostate biopsy

open access: yesBJUI Compass, Volume 6, Issue 8, August 2025.
Abstract Objective To evaluate the carbon footprint of transperineal prostate biopsy (TPPB). Climate change is the biggest global public health threat of the 21st century. Healthcare contributes 5% to global greenhouse gas emissions. Despite growing enthusiasm for sustainable urology, there is little data on the environmental impact of urological ...
Daniel A. Carson   +5 more
wiley   +1 more source

The role of radiotherapy in pelvic nodal recurrence following definitive treatment for prostate cancer. [PDF]

open access: yesCurr Opin Urol
Dematteis A   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy